INS and type 2 diabetes mellitus: Augmented activity of the mTOR complex could promote an inability of β-cells to release insulin through an inhibitory effect on the mentioned kinase, leading to cellular insulin resistance and contributing to the development of type 2 diabetes (Figure 2).